In Boston, strain engineering pioneer Ginkgo Bioworks Holdings has received notice from the New York Stock Exchange that the company’s average stock closing price was less than $1 per share over a consecutive 30 trading-day period—setting a countdown for Ginko to boost its price or be delisted. Under the NYSE rules, Ginkgo now has a […]
In Japan, Sojitz and Ginkgo Bioworks have entered into a binding definitive agreement. Together, Sojitz and Ginkgo aim to build connections with key Japanese businesses and encourage the use of synthetic biology to develop sustainable production processes. Sojitz Corporation and Ginkgo will collaborate in a joint business development effort to offer Ginkgo’s R&D services to […]
In Massachusetts, Ginkgo Bioworks announced that a Ginkgo-led team — including partners from the Pacific Northwest National Laboratory, Colorado School of Mines, and Global Algae Innovations — has been awarded funding through the U.S. Department of Energy’s (DOE) Bioenergy Technologies Office (BETO). The scope of the project will be to develop a new approach to […]
